Mechanical Thrombectomy for Medium Vessel Occlusion with Extracranial Vessel Tortuosity Using Quadruple Coaxial System: A Case Series.

Objective: Medium vessel occlusions (MeVOs) during acute ischemic stroke present challenges due to their distal occlusion sites. Furthermore, MeVO cases with tortuous extracranial vessels are complex, and effective management techniques are lacking. This study reports the utility of combining a 6-French distal access catheter with a low-profile aspiration catheter, guiding catheter, and microcatheter to establish a quadruple coaxial system for treating MeVOs with tortuous extracranial vessels.

Methods: We retrospectively reviewed data from mechanical thrombectomy cases with MeVO at our institution between March 2022 and February 2024. A total of 81 patients were enrolled, and 5 patients were treated using the quadruple coaxial system. The primary efficacy outcome was the first pass effect (FPE), and the rate of successful recanalization, determined by the expanded thrombolysis in cerebral infarction (eTICI 2b/3) at the end of treatment. The safety assessment included hemorrhagic and procedure-related complications.

Results: Of the 81 enrolled patients, 5 patients were treated using the quadruple coaxial system. Three men and 2 women, with a mean age of 77 years, were included in this study. The median baseline National Institutes of Health Stroke Scale score was 10 points, and a tissue plasminogen activator was administered to 2 patients. Four patients had M2 occlusions, and 1 patient had a P2 occlusion. In 4 cases, the guiding system could not be advanced distally because of extracranial vessel tortuosity. The quadruple coaxial system achieved a significantly higher rate of FPE (80% vs. 30%; P = 0.0401) than the standard coaxial system, with no postoperative intracerebral hemorrhage or procedure-related complications.

Conclusion: The quadruple coaxial system is a valuable approach for treating MeVOs with severe extracranial vessel tortuosity. This system offers a reliable and safe treatment modality when a guiding system cannot be advanced distally.